A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2.
Drugs currently used for treating Parkinson's disease patients provide symptomatic relief without altering the neurodegenerative process. Our aim was to examine the possibility of using DJ-1 (PARK7), as a novel therapeutic target for Parkinson's disease. We designed a short peptide, named...
Main Authors: | Nirit Lev, Yael Barhum, Tali Ben-Zur, Israel Aharony, Lena Trifonov, Noa Regev, Eldad Melamed, Arie Gruzman, Daniel Offen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4449207?pdf=render |
Similar Items
-
DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS.
by: Nirit Lev, et al.
Published: (2015-01-01) -
DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury.
by: Lior Molcho, et al.
Published: (2018-01-01) -
Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy.
by: Micaela Johanna Glat, et al.
Published: (2016-01-01) -
Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.
by: Javier Ganz, et al.
Published: (2014-01-01) -
Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury.
by: Adi Shruster, et al.
Published: (2012-01-01)